RMTC Advises 72-Hour Bute Withdrawal Under ADMC Program
Description:
The RMTC has been informed that HISA's Anti-Doping and Medication Control Program has proposed enforcing the screening limit of phenylbutazone at 300 ng/mL in blood, rather than the previously established screening limit of 200 ng/mL in blood.